The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPG.L Regulatory News (PPG)

  • There is currently no data for PPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing and Appointment of Joint Broker

14 Nov 2018 08:11

RNS Number : 3064H
Plutus PowerGen PLC
14 November 2018
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

Plutus PowerGen Plc / Ticker: PPG / Index: AIM

14 November 2018

PLUTUS POWERGEN PLC

("Plutus", the "Group" or the "Company")

 

Placing and Appointment of Joint Broker

 

Plutus PowerGen PLC (AIM: PPG), the AIM listed power company focused on the development and operation of flexible energy generation ("FlexGen") projects and gas powered generation sites ("peakers") in the UK, is pleased to announce that it has raised £500,000 gross through the issue of 83,333,333 ordinary shares of 0.1 pence each ("New Ordinary Shares") at an issue price of 0.6 pence per share (the "Issue Price") in a placing conducted by Turner Pope Investments ("TPI") Limited (the "Placing"). The net proceeds of the Placing will be utilised in the development of wholly owned gas peaker sites and for general working capital purposes.

 

The Company has a strong track record in the power generation arena, having already developed six operating 20MW FlexGen sites to date, and is making a strategic shift to the development of higher margin gas operations, in which it will hold higher equity interests. The Company has a substantial pipeline of over 300MW of gas assets and is also advancing two 20MW gas powered generation sites in-house which, it is estimated, will run on a merchant basis for between 1,250 and 2,500 hours per annum. Whilst these projects are well advanced and shortly due to enter planning, they require further working capital to complete. The Company is also aiming to pursue two further 20MW sites, which the Board estimates will cost between £600,000 and £1 million if acquired from a third party. Furthermore, the Company is issuing an additional 18,000,000 ordinary shares of 0.1 pence each, at the Issue Price, in lieu of fees.

 

The Issue Price represents a discount of 11.1 per cent. to the mid-market closing price of 0.0675 pence on 13 November 2018. The Placing is not being underwritten and is conditional only on admission of the New Ordinary Shares to trading on AIM ("Admission"). The Placing is being conducted pursuant to the existing authorities granted to the Directors of the Company at its annual general meeting on 1 November 2018 and therefore no further shareholder approval is required. The New Ordinary Shares represent approximately 12.3 per cent. of the Company's issued share capital as enlarged by the New Ordinary Shares.

 

Application will be made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM and it is expected that such Admission will occur at 8.00 a.m. on 28 November 2018. The New Ordinary Shares will be issued credited as fully paid and will rank in full for all dividends and other distributions declared, made or paid after Admission, respectively and will otherwise be identical to and rank on Admission pari passu in all respects with the existing ordinary shares of 0.1 pence ("Ordinary Shares"). The New Ordinary Shares are not being made available to the public and are not being offered or sold in or into any jurisdiction where it would be unlawful to do so.

 

Following Admission, the Company will therefore have 825,262,268 Ordinary Shares in issue, none of which will be held in treasury.

 

Appointment of Joint Broker

 

Turner Pope Investments ("TPI") Limited has been appointed as the Company's joint broker with immediate effect.

 

Plutus acting CEO James Longley said, "The Company will make significant savings developing sites in-house by pursuing this small placing and we will be able to offer greater returns to direct investors in the vehicles used for the 20MW gas sites. Additionally, there is a significant uplift to Plutus via the valuation of these sites once planning and site assembly is completed. We continue to work to secure the appropriate funding for our strong pipeline of sites and build a company that assists in alleviating the UK's current and forecast risk of an energy deficit."

 

**ENDS**

 

For further information, please visit www.plutuspowergen.com, or contact:

 

Charles Tatnall

Plutus PowerGen Plc

Tel: +44 (0) 20 8720 6562

David Foreman

Cantor Fitzgerald Europe

Tel: +44 (0) 207 894 7000

Richard Salmond

Cantor Fitzgerald Europe

Tel: +44 (0) 207 894 7000

Andy Thacker

Turner Pope

Tel: +44 (0) 20 3621 4120

Isabel de Salis

St Brides Partners Limited

Tel: +44 (0) 20 7236 1177

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGGGBUGUPRURC
Date   Source Headline
15th Oct 20121:00 pmRNSDisposal
10th Oct 20127:30 amRNSStatement re. Suspension
10th Oct 20127:30 amRNSSuspension - IPSO Ventures Plc
29th Aug 20127:00 amRNSHolding(s) in Company
10th Aug 20127:00 amRNSDirector/PDMR Shareholding
3rd Aug 201212:40 pmRNSReplacement - Director Shareholding
3rd Aug 20127:00 amRNSDirector/PDMR Shareholding
15th Jun 20127:00 amRNSHolding(s) in Company
18th Apr 20127:00 amRNSDirector/PDMR Shareholding
29th Feb 20127:00 amRNSTotal Voting Rights
8th Feb 20127:00 amRNSIssue of equity, directors' shareholdings and TVR
23rd Jan 20127:01 amRNSHalf Yearly Report
17th Jan 20124:30 pmRNSHolding(s) in Company
30th Nov 20117:00 amRNSTotal Voting Rights
18th Nov 20117:00 amRNSIssue of Equity
14th Nov 20112:00 pmRNSDirector/PDMR Shareholding
1st Nov 20114:20 pmRNSChange of Registered Office
24th Oct 20117:00 amRNSAIM Rule 17 Disclosures
12th Oct 20117:00 amRNSIPSol Energy successful fund raising
3rd Oct 20115:15 pmRNSHolding(s) in Company
30th Sep 201110:00 amRNSTotal Voting Rights
30th Sep 20119:00 amRNSHolding(s) in Company
22nd Sep 20111:50 pmRNSHolding(s) in Company
15th Sep 20112:15 pmRNSEU grants approval for Buccolam
9th Sep 20111:00 pmRNSResult of AGM
25th Aug 20111:35 pmRNSIssue of Equity and Director Dealings
19th Aug 20117:00 amRNSFinal Results
8th Aug 20117:00 amRNSDirectorate Changes
12th Jul 20117:00 amRNSTermination of Loughborough University agreement
7th Jul 201110:35 amRNSCompletion of placing to raise £195,000
1st Jul 20117:00 amRNSTherakind Product Update
29th Jun 20111:05 pmRNSResult of General Meeting
27th Jun 20117:00 amRNSFurther re General Meeting
24th Jun 20117:00 amRNSHolding(s) in Company
22nd Jun 20114:58 pmRNSHolding(s) in Company
22nd Jun 20117:00 amRNSShareholding in Biocroi
13th Jun 20113:50 pmRNSProposed Placing to raise £195,000/Notice of GM
25th May 20115:10 pmRNSHolding(s) in Company
24th May 20117:00 amRNSCambridge Meditech agreement with Lantor (UK)
25th Mar 20117:00 amRNSTrading update
11th Feb 20117:00 amRNSHolding(s) in Company
8th Feb 20111:30 pmRNSHolding(s) in Company
26th Jan 20113:30 pmRNSHolding(s) in Company
5th Jan 20117:00 amRNSHalf Yearly Report
8th Oct 20103:15 pmRNSDirector/PDMR Shareholding
8th Oct 20108:00 amRNSDirectorate Change
13th Sep 20107:00 amRNSAllotment of Adviser Shares
10th Sep 201012:30 pmRNSResult of AGM
27th Aug 201012:20 pmRNSResult of General Meeting
20th Aug 20107:00 amRNSPosting of Annual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.